APOE ε4 allele distribution demonstrated the expected pattern associated with AD risk (p = 1.50 × 10−219), with controls showing the lowest frequency of ε4 carriers (24.7 %) compared to AD patients (49.2 % carriers) and AD + Stroke patients (47.0 % carriers). This evidence concerns the gene APOE and stroke disorder.